Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Population modification strategies based on transgenic mosquitoes carrying genes that prevent parasite transmission play a role in the malaria eradication agenda. They can consolidate elimination gains by providing barriers to parasite and competent vector reintroduction, and allow resources to be focused on new sites while providing confidence that treated areas will remain malaria-free. Strategic planning in selecting field sites, engineered mosquito strains, trial designs, and implementation strategies is needed to achieve a successful first field trial. The trial should use local scientists and adhere to stringent community engagement and regulatory standards. The trial should have an epidemiological end point that results in local disease elimination.

Original publication





Book title

Genetic Control of Malaria and Dengue

Publication Date



423 - 444